Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211992 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Actual shortage | 2024-01-11 | 2024-05-23 | 215722 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Actual shortage | 2024-02-08 | 2024-02-15 | 218940 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Actual shortage | 2024-02-29 | 2024-04-25 | 220983 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2017-08-02 | 2018-03-13 | 18033 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2022-01-20 | 2022-06-16 | 153189 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190683 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-09-19 | 2023-10-26 | 204769 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-11-16 | 2024-03-28 | 210440 |
| ACT PIOGLITAZONE | 45MG | TABLET | Resolved | 2020-03-12 | 2022-04-21 | 108625 |
| ACT PIOGLITAZONE | 45MG | TABLET | Actual shortage | 2024-01-18 | 2024-01-18 | 216454 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 4G 0.5G | POWDER FOR SOLUTION | Actual shortage | 2017-11-16 | 2018-10-11 | 29438 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 4MG 1.25MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110703 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1006 |
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2017-08-24 | 2017-10-10 | 20315 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42635 |
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61352 |
| TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-01-30 | 2020-03-19 | 104902 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108012 |
| TEVA-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2020-03-26 | 2020-05-14 | 109577 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |